Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

NCT07682792 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Mycosis Fungoides/Sezary Syndrome
T-cell Large Granular Lymphocytic Leukemia

Interventions

DRUG: Golidocitinib

Sponsor

Washington University School of Medicine

Collaborators

[object Object]